Advertisement
Pakistan Officially starts Production of COVID-19 Vaccine
National Institute of Health (NIH) has started the local manufacturing of CanSinoBIO’s COVID-19 vaccine after importing the raw material from China.
According to a statement by NIH, the raw material imported from the neighboring country is sufficient to produce 120,000 doses, which will be available for use by the end of May.
NIH researchers are working along with Chinese scientists for the manufacturing of CanSinoBIO’s COVID-19 vaccine.
Advertisement
Last month, NIH had announced plans to start local production of CanSinoBIO’s vaccine in May.
Related stories
HealthChildhood Cancer: Four Warning Signs Parents Should Know
HealthCloves May Help Strengthen Bones, Research Suggests
HealthHealth Minister: 2D Barcodes Mandatory on All Medicines
HealthToo Much of a Good Thing: How Overeating Healthy Foods Can Harm Your Body
· 2 min read
HealthDRAP Makes 2D Barcodes Mandatory on All Medicines: How to Verify Your Medicine by Scanning
Health